Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at


The disclosure generally provides a WRrNYVAC comprising multiple antigens from different stages of a malaria parasite (Plasmodium) life cycle, methods for producing them, immunogenic vaccine formulations comprising WRrNYVAC, such as P. vivax containing formulations (WRPvrNYVAC) and P. falciparum containing formulations (WRPfrNYVAC) and methods for the prevention and/or treatment of malaria infections and poxvirus infections.

Docket:WRAIR 16-18-US02

Publication/Issued No.:11,013,791

Publication/Issue Date:2021-05-25

Categories: Vaccine

More Detail:Visit USPTO.GOVExternal link


Inventor(s):HAUNS, K.

For Licensing Opportunities, please contact the ORTA at

Last Modified Date: 25 Jul 2023

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at: or by telephone at (301)619-2736.